MT-2 (Melanotan II)
Less selective alpha-MSH analog. Stronger pigmentation than MT-1, but also hits libido and brings rougher side effects.
MT-2 is the more potent (and rougher) sibling of MT-1. Stronger pigmentation but harder side-effect profile, including unwanted libido effects. Most people who tried MT-2 first migrate to MT-1 for cleaner results.
Not FDA approved. Afamelanotide (MT-1) is the approved analog.
Not formally categorized in the FDA bulks lists.
Not prescribed in conventional medicine.
Who it's for
- →Users wanting deeper pigmentation than MT-1 delivers
- →People who specifically want the libido side effect
- →Anyone who tolerated the nausea/flush profile in past use
What to expect
- Week 1
Strong nausea early, facial flush, spontaneous erections in male users.
- Week 4
Visible pigmentation if UV exposure paired. Side effects fade.
- Week 8
Maintenance dosing holds tan with weekly use.
Dosing protocol
Loading: 250-500 mcg sub-q daily for 1-2 weeks. Maintenance: 250-500 mcg, 2-3x weekly. Pair with UV exposure.
Stacks well with
Side effects
When NOT to use
- ⚠Personal history of melanoma
- ⚠Atypical mole syndrome
- ⚠Pregnancy / nursing
Common mistakes
- • Starting at full dose instead of titrating up — nausea hits hard
- • Skipping the mole-map baseline
- • Confusing dosing with MT-1 (different side effect profile)
Educational only. User-specific dosing is between you and a qualified provider.